Results 111 to 120 of about 9,340 (184)

Mepolizumab treatment is associated with physical activity and cardiorespiratory fitness irrespective of endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyps: a randomised controlled trial. [PDF]

Eur Clin Respir J
Jens T, Morten H, Anne-Sophie H, Lukas M, Kasper A, Howraman M, Vibeke B.   +6 more
europepmc   +1 more source

Comparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study. [PDF]

Respir Res
Bourdin A, Canonica GW, Virchow JC, Borsos K, Stanford RH, Ledanois O, Kwah J, Ge W, Huynh L, Duh MS, Boca AE, Cheng WH, Gandhi A.   +12 more
europepmc   +1 more source

Mepolizumab for eosinophilic COPD with frequent exacerbations: single-centre real-world experience in a phenotype-directed approach. [PDF]

Ther Adv Respir Dis
Šarc I, Morgan T, Požek I, Kopač P.
europepmc   +1 more source

Efficacy and safety of mepolizumab in severe eosinophilic asthma: a systematic review and meta-analysis. [PDF]

J Thorac Dis
Li Y, Li J, Yang H, Wu L.
europepmc   +1 more source

Refractory erythroderma in idiopathic hypereosinophilic syndrome: A case treated with mepolizumab and abrocitinib. [PDF]

SAGE Open Med Case Rep
Elhaj H, Al Amari A, Alyaqout F, Ben-Shoshan M, Netchiporouk E, Fein M.   +5 more
europepmc   +1 more source

Proteomic Identification of Plasma Biomarkers of Response to IL-5 Inhibitor Biologics in Healthy Subjects. [PDF]

Clin Transl Sci
Chekka LMS, Samarth DP, Howard KE, Guo Y, Mohamed EG, Decker E, Wheeler W, Wommack J, Gogain J, Deering J, Schrieber SJ, Wang YM, Strauss DG, Florian J, Hyland PL.   +14 more
europepmc   +1 more source

Mepolizumab treatment alters the functional phenotype of eosinophils in severe eosinophilic asthma. [PDF]

Front Immunol
Miguéns-Suárez P, Martelo-Vidal L, Vázquez-Mera S, Blanco-Aparicio M, Calvo-Álvarez U, González-Fernández C, Mosteiro-Añón M, Corbacho-Abelaira D, Hermida-Valverde T, Calvo-Henríquez C, Nieto-Fontarigo JJ, Salgado FJ, González-Barcala FJ.   +12 more
europepmc   +1 more source

Real-world outcomes after anti-IL-5/anti-IL-5Rα treatment for hypereosinophilic syndrome: Systematic literature review. [PDF]

J Allergy Clin Immunol Glob
Jain P, Rowell J, Edmonds C, Stokes M, Ding N, Chen SY.   +5 more
europepmc   +1 more source

The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis. [PDF]

Arthritis Rheumatol
Nair PK, Hellmich B, Bourdin A, Jayne DRW, Roufosse F, Khalidi N, Börjesson Sjö L, Fan Y, McCrae C, Necander S, Rodríguez-Suárez E, Shavit A, Walton C, Merkel PA, Wechsler ME.   +14 more
europepmc   +1 more source

A Prospective Observational Study Evaluating the Efficacy of Omalizumab and Mepolizumab in Patients With Severe Asthma. [PDF]

Cureus
Makhlooq M, Qader A, Salman MR, Al-Omran Z, Allawi A, Zaid T, Mahdi M.   +6 more
europepmc   +1 more source